Suchergebnisse - "*Coronavirus Infections"

PubPharm (4.652)

141

COVID-19 Antigen Rapid Test Evaluation in Low-Prevalence Setting : Performance Assessment of COVID-19 Antigen Rapid Diagnostic Tests and Algorithms in Low-Prevalence Settings

enthalten in: ClinicalTrials.gov | 2023

142

Acute non-calculous cholecystitis in a young aged patient with COVID-19 : A case report

enthalten in: Terapevticheskii arkhiv | 2023

von Salukhov, V. | Lopatin, Y. | Minakov, A. | +2

143

LEAP-CT for Treatment of COVID-19 Patients (Master Protocol) : Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) to Evaluate the Safety and Efficacy of Drug Combinations in COVID-19 Patients

enthalten in: ClinicalTrials.gov | 2023

144

Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1) : A Phase 2 Randomized, Single-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of the Combination of Famotidine and Celecoxib as a Treatment in Moderate-to-severe Patients Hospitalized for COVID-19

enthalten in: ClinicalTrials.gov | 2023

145

In-depth Immunological Investigation of COVID-19. : In-depth Characterisation of the Dynamic Host Immune Response to Coronavirus SARS-CoV-2

enthalten in: ClinicalTrials.gov | 2023

146

Camostat With Bicalutamide for COVID-19 : COMBO Trial: Camostat With Bicalutamide for COVID-19

enthalten in: ClinicalTrials.gov | 2023

147

Intravenous Zotatifin in Adults With Mild or Moderate COVID-19 : A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Trial of Intravenous Zotatifin in Adults With Mild or Moderate Coronavirus Disease 2019 (COVID-19)

enthalten in: ClinicalTrials.gov | 2023

148

SPI-1005 Treatment in Severe COVID-19 Patients : A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety and Efficacy of SPI-1005 in Severe COVID-19 Patients

enthalten in: ClinicalTrials.gov | 2023

149

SPI-1005 Treatment in Moderate COVID-19 Patients : A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety and Efficacy of SPI-1005 in Moderate COVID-19 Patients

enthalten in: ClinicalTrials.gov | 2023

150

COVID-19 Immune Repertoire Sequencing : COVID-19 Immune Repertoire Sequencing

enthalten in: ClinicalTrials.gov | 2023